Stroke Trial, Recruiting NCT04205279 Sponsor: University of Illinois at Chicago Condition: Stroke
Back to Stroke

Stroke Trial, Recruiting

NCT04205279
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

Healthy younger adults (ages 18–55):

  • People aged 18 to 55 years
  • People with no diagnosed neurological, heart, lung, muscle, bone, or other ongoing or sudden health conditions
  • People who have not had major surgery in the last 6 months or a hospital stay in the last 3 months
  • People who are not taking sedative (calming or sleep-inducing) medications
  • People who can understand and communicate in English

Healthy older adults (ages 56–90):

  • People aged 56 to 90 years
  • People with no diagnosed neurological, heart, lung, muscle, bone, or other ongoing or sudden health conditions
  • People who have not had major surgery in the last 6 months or a hospital stay in the last 3 months
  • People who are not taking sedative medications
  • People who are able to walk at least 10 metres, with or without a walking aid
  • People who can understand and communicate in English
  • People whose balance score (measured by a standard balance test called the Berg Balance Scale) is below 45 out of 56

People who have had a stroke (ages 18–90):

  • People aged 18 to 90 years who have had a stroke (self-reported)
  • People whose stroke occurred more than 6 months ago
  • People with no other neurological conditions besides stroke, and no heart, lung, muscle, bone, or other ongoing health conditions
  • People who have not had major surgery in the last 6 months or a hospital stay in the last 3 months
  • People who are not taking sedative medications
  • People who are able to walk at least 10 metres, with or without a walking aid
  • People who can understand and communicate in English

Who may not be able to join:

All groups:

  • People whose heart rate, blood pressure, or blood oxygen levels fall outside safe ranges at the start of testing (the trial site will measure these before proceeding)
  • People who weigh more than 250 pounds (approximately 113 kg)

Healthy older adults and stroke survivors (additional criteria):

  • People whose heel bone density scan shows a result classified as osteoporosis (a T-score below -2)
  • People whose score on a standard memory and thinking test (the Mini-Mental State Exam) is below 25 out of 30, which may indicate mild cognitive impairment
  • People who, during a 6-minute walking test, experience significant shortness of breath, uncontrolled pain (rated above 3 out of 10), a drop in blood oxygen to below 92%, or who are unable to walk the minimum expected distance for their age

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 7 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Tanvi Bhatt, PhD, University of Illinois at Chicago

Phone: 3123552735

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
University of Illinois at Chicago
Registry
ClinicalTrials.gov
Start date
1 February 2018
Est. completion
31 May 2027

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Change in Stability gain or loss; Change in Limb support gain or loss; Change in laboratory-induced falls; Number of Real life falls

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 7 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov